Reasons for hormonal contraceptive use in a cohort of African-American women living in the Detroit area-Reference-Cited by-同舟云学术

Reasons for hormonal contraceptive use in a cohort of African-American women living in the Detroit area

Published:2020-11 Issue:5 Volume:102 Page:346-348
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Hoffman Sarah R.^ORCID,Nicholson Wanda K.,Smith Jennifer S.,Jonsson Funk Michele,Hudgens Michael G.,Poole Charles,Baird Donna D.,Harmon Quaker E.

Funder

Intramural Research Program of the NIH

National Institute of Environmental Health Sciences

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference11 articles.

1. Current contraceptive use in the United States, 2006–2010, and changes in patterns of use since 1995;Jones;Natl Health Stat Report,2012

2. Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013;Daniels;Natl Heal Stat Rep,2015

3. Contraceptive methods women have ever used: United States, 1982–2010;Daniels;Natl Health Stat Report,2013

4. Hoffman SR. National Survey of Family Growth (NSFG) Code 2019. GitHub repository, https://github.com/srhoffma/NSFG

5. Regulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000–2015: a retrospective data analysis;Troskie;C Open,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women;PLOS ONE;2024-05-23

2. Physiologically‐based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug–drug interactions;CPT: Pharmacometrics & Systems Pharmacology;2024-01-15

3. Employment Status in the United States and Use of Long-Acting Reversible Contraception or Moderately Effective Contraception before and after the Affordable Care Act: National Survey of Family Growth 2006–2010 and 2015–2017;Preventive Medicine Reports;2023-06

4. Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma;Obstetrics & Gynecology;2022-04-05

5. Contraceptive provision in Oregon school-based health centers: Method type trends and the role of Title X;Contraception;2021-08